Drug:
Reaction: PARAESTHESIA
20250101 - 20251231
No. 801 - 900
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 801 | 25684078 |
CA |
66 | 1 |
Abdominal distension, Abdominal pain, Abdominal pain upper, Affect lability, Anxiety, Blood potassium decreased, Chills, Fatigue, Flatulence, Hypertension, Inappropriate schedule of product administration, Injection site discomfort, Injection site haemorrhage, Injection site pain, Musculoskeletal stiffness, Paraesthesia, Post procedural diarrhoea, Procedural complication, Procedural pain, Tinnitus, |
||||
DARATUMUMAB, LANREOTIDE ACETATE, LANREOTIDE ACETATE, CYANOCOBALAMIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, HYDROCHLOROTHIAZIDE, PREGABALIN, ROSUVASTATIN, TELMISARTAN, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 802 | 25684195 |
GB |
||
Paraesthesia, |
||||
| 803 | 25684386 |
US |
2 | |
Spinal fracture, Restless legs syndrome, Paraesthesia, Headache, Bone pain, Back pain, Insomnia, Gait disturbance, Somnolence, Dizziness, Pain, Procedural pain, |
||||
ABALOPARATIDE, ABALOPARATIDE, POLYETHYLENE GLYCOL 400, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LOSARTAN POTASSIUM, LOSARTAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, GABAPENTIN, |
||||
| 804 | 25684457 |
US |
71 | 1 |
Nightmare, Paraesthesia, Pain, Swelling, Muscle spasms, Prostatic specific antigen increased, Dizziness, Hot flush, Fatigue, Therapeutic response unexpected, |
||||
RELUGOLIX, RELUGOLIX, ENZALUTAMIDE, CYCLOBENZAPRINE, FUROSEMIDE, GABAPENTIN, NIFEDIPINE, PANTOPRAZOLE, VALSARTAN, VALSARTAN ORAL, AMLODIPINE, LOPERAMIDE HYDROCHLORIDE, PREDNISONE, DIPHENHYDRAMINE HYDROCHLORIDE, PROMETHAZINE, PROMETHAZINE, |
||||
| 805 | 25684612 |
US |
64 | 1 |
Nerve compression, Hypoaesthesia, Paraesthesia, |
||||
UPADACITINIB, |
||||
| 806 | 25684691 |
GB |
2 | |
Erythema, Paraesthesia, Injection site reaction, |
||||
RISANKIZUMAB-RZAA, |
||||
| 807 | 25684757 |
US |
2 | |
Paraesthesia, Product dose omission issue, |
||||
MEPOLIZUMAB, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, CALCIUM, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CETIRIZINE HYDROCHLORIDE, ERGOCALCIFEROL, AMLODIPINE BESYLATE, TOPIRAMATE, TOPIRAMATE SPINKLE, FLUOXETINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, CARVEDILOL, ZOLPIDEM TARTRATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, FLUOXETINE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ERGOCALCIFEROL, |
||||
| 808 | 25684769 |
US |
66 | 2 |
Hypoaesthesia, Paraesthesia, Pain, |
||||
EPLONTERSEN, |
||||
| 809 | 25684969 |
68 | 2 | |
Rectal haemorrhage, Abdominal pain lower, Muscle spasms, Paraesthesia, Frequent bowel movements, Nausea, Decreased appetite, Hyperhidrosis, Dehydration, Neutropenia, Diverticulitis, Blood lactic acid increased, |
||||
FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, LEUCOVORIN CALCIUM, |
||||
| 810 | 25685126 |
CH |
42 | 1 |
Neutropenic colitis, Febrile neutropenia, Otitis media, Sinusitis, Immunoglobulins decreased, Paraesthesia, |
||||
MELPHALAN HYDROCHLORIDE, MELPHALAN, MELPHALAN HYDROCHLORIDE, MELPHALAN, BENDAMUSTINE HCL, BENDAMUSTINE HCL, CYTARABINE, CYTARABINE, RITUXIMAB, RITUXIMAB, FILGRASTIM, FILGRASTIM, |
||||
| 811 | 25685161 |
CA |
50 | 2 |
Adverse drug reaction, Bone cancer, Dyspnoea, Hepatic enzyme abnormal, Hepatic neoplasm, Hormone receptor positive HER2 negative breast cancer, Liver disorder, Metastases to eye, Mucosal inflammation, Neutropenia, Paraesthesia, Skeletal injury, Suspected counterfeit product, Tachycardia, |
||||
FULVESTRANT, FULVESTRANT, TAMOXIFEN CITRATE, GOSERELIN, GOSERELIN, PACLITAXEL, PALBOCICLIB, CAPECITABINE, |
||||
| 812 | 25685750 |
US |
||
Paraesthesia, |
||||
RIMEGEPANT SULFATE, |
||||
| 813 | 25686014 |
JP |
66 | 2 |
Neuropathy peripheral, Limb discomfort, Paraesthesia, Hot flush, Weight increased, Dysaesthesia, Paronychia, Constipation, Gastrointestinal motility disorder, Dizziness, Gait disturbance, Hepatic function abnormal, |
||||
LAROTRECTINIB, LAROTRECTINIB, |
||||
| 814 | 25686162 |
US |
84 | 2 |
Deafness, Paraesthesia, Peripheral swelling, Chills, Alopecia, Effusion, Poor quality sleep, Pruritus, Erythema, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 815 | 25686274 |
EU |
59 | 2 |
Paraesthesia, Hypoaesthesia, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 816 | 25686496 |
US |
53 | 2 |
Swelling face, Paraesthesia, Adrenal insufficiency, Migraine, Diarrhoea, Sepsis, Vomiting, Product dose omission issue, |
||||
PREDNISONE, |
||||
| 817 | 25678684 |
US |
2 | |
Paraesthesia, Erythema, Eye irritation, Product packaging issue, |
||||
ERYTHROMYCIN, BEPOTASTINE BESILATE, |
||||
| 818 | 25679124 |
GB |
65 | 2 |
Paraesthesia, |
||||
| 819 | 25679248 |
US |
62 | |
Neuropathy peripheral, Nausea, Urticaria, Paraesthesia, Burning sensation, Arthralgia, |
||||
CEPHALEXIN, CEPHALEXIN, |
||||
| 820 | 25679347 |
US |
67 | 2 |
Hemiplegic migraine, Neurological symptom, Hemiparesis, Paraesthesia, Headache, Tremor, |
||||
REGADENOSON, REGADENOSON ANHYDROUS, |
||||
| 821 | 25679439 |
GB |
1 | |
Musculoskeletal stiffness, Paraesthesia, |
||||
| 822 | 25679485 |
EU |
26 | 1 |
Dizziness, Drug ineffective, Paraesthesia, Fatigue, |
||||
ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, |
||||
| 823 | 25679615 |
CA |
43 | 2 |
Abdominal pain upper, Blepharospasm, Drug ineffective, Drug intolerance, Epilepsy, Gastrooesophageal reflux disease, Hypoaesthesia, Memory impairment, Migraine, Off label use, Pain, Paraesthesia, Rash, Red blood cell sedimentation rate increased, Respiratory disorder, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Sleep disorder, Sleep disorder due to a general medical condition, Stomatitis, Swollen joint count increased, Swelling, Synovitis, Taste disorder, Vomiting, Adverse event, Hospitalisation, |
||||
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ABATACEPT, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, FLUTICASONE FUROATE, FLUTICASONE FUROATE, FLUTICASONE FUROATE, AZELAIC ACID, AZELAIC ACID, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, ONABOTULINUMTOXINA, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, BUPRENORPHINE HYDROCHLORIDE, BUPRENORPHINE, CALCIUM, CALCIUM GLUCONATE, CANDESARTAN, CANDESARTAN, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CORTISONE ACETATE, SECUKINUMAB, CYCLOBENZAPRINE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ERENUMAB-AOOE, ERGOCALCIFEROL, ERGOCALCIFEROL, LEVOMILNACIPRAN HYDROCHLORIDE, LEVOMILNACIPRAN HYDROCHLORIDE, AZELAIC ACID, AZELAIC ACID, AZELAIC ACID, FLUTICASONE FUROATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FOLIC ACID, ALENDRONATE SODIUM, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, ADALIMUMAB-ADAZ, INFLIXIMAB, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LEVOMILNACIPRAN, MAGNESIUM CARBONATE, MAGNESIUM CHLORIDE, MAGNESIUM CHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, MILNACIPRAN HYDROCHLORIDE, MILNACIPRAN HYDROCHLORIDE, MIRABEGRON, MIRABEGRON, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NICOTINAMIDE, APREMILAST, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE, PHOSPHORUS, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, RITUXIMAB, RITUXIMAB, ERGOCALCIFEROL, LEFLUNOMIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, THIAMINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE, TRETINOIN, TRETINOIN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, VITAMIN A, CYANOCOBALAMIN, CYANOCOBALAMIN, CYANOCOBALAMIN, ERGOCALCIFEROL, ERGOCALCIFEROL, TOFACITINIB, CALCIUM CARBONATE, ANTACID, |
||||
| 824 | 25679779 |
US |
72 | 2 |
Perineal rash, Infusion related reaction, Paraesthesia, |
||||
AMIVANTAMAB, AMIVANTAMAB, CARBOPLATIN, CARBOPLATIN, |
||||
| 825 | 25679814 |
EU |
38 | 1 |
Suicidal ideation, Aggression, Product substitution issue, Abdominal pain, Irritability, Muscular weakness, Paraesthesia, Asthenia, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 826 | 25679836 |
GB |
37 | 2 |
Withdrawal syndrome, Nausea, Fatigue, Dizziness, Diarrhoea, Paraesthesia, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 827 | 25679947 |
US |
34 | 2 |
Serotonin syndrome, Head discomfort, Hypoaesthesia, Accidental overdose, Paraesthesia, Burning sensation, Headache, |
||||
LUMATEPERONE, LUMATEPERONE, OLANZAPINE, OLANZAPINE PAMOATE, |
||||
| 828 | 25680037 |
CA |
40 | 2 |
Rash, Ill-defined disorder, Duodenal ulcer perforation, Synovitis, Fall, Taste disorder, Breast cancer stage III, Impaired healing, Stomatitis, Nausea, Product use in unapproved indication, Drug intolerance, Underdose, Rheumatoid arthritis, Hepatitis, Abdominal discomfort, Liver injury, Dyspnoea, Gait inability, Wound infection, Dyspepsia, Muscle spasms, Drug hypersensitivity, Migraine, Obesity, Injection site reaction, Folliculitis, Back injury, Hepatic enzyme increased, Hypercholesterolaemia, Memory impairment, Lung disorder, Weight increased, Onychomycosis, Onychomadesis, Contraindicated product administered, Off label use, Liver function test increased, Pneumonia, Musculoskeletal pain, Rheumatic fever, Blister, Hand deformity, Therapeutic product effect decreased, Overdose, Maternal exposure during pregnancy, Asthenia, Product label confusion, Intentional product use issue, Peripheral swelling, Injury, Muscular weakness, Insomnia, Osteoarthritis, Nasopharyngitis, Coeliac disease, Pain in extremity, Blepharospasm, Psoriatic arthropathy, Treatment failure, Helicobacter infection, Neck pain, Wound, Anti-cyclic citrullinated peptide antibody positive, Depression, Mobility decreased, Blood cholesterol increased, Hypoaesthesia, Joint swelling, Drug-induced liver injury, Arthralgia, Facet joint syndrome, Grip strength decreased, Irritable bowel syndrome, Drug ineffective, Decreased appetite, Headache, Abdominal pain upper, Inflammation, Musculoskeletal stiffness, Joint range of motion decreased, Adverse reaction, Pain, Systemic lupus erythematosus, C-reactive protein abnormal, Peripheral venous disease, Dizziness, Finger deformity, C-reactive protein increased, Type 2 diabetes mellitus, Hypersensitivity, Malaise, Exposure during pregnancy, General physical health deterioration, Fibromyalgia, Gastrooesophageal reflux disease, Sleep disorder, Confusional state, Night sweats, Alopecia, Diarrhoea, Urticaria, Condition aggravated, Gastrointestinal disorder, Vomiting, Lower respiratory tract infection, Dry mouth, Swelling, Pemphigus, Lip dry, Arthropathy, Epilepsy, Pericarditis, Abdominal distension, Product quality issue, Hypertension, Bursitis, Muscle injury, Paraesthesia, Glossodynia, Infusion related reaction, Nail disorder, Live birth, Incorrect product administration duration, Fatigue, Wheezing, |
||||
CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ATOMOXETINE, AZATHIOPRINE, ADALIMUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, SECUKINUMAB, MEPOLIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, BUPRENORPHINE, ERENUMAB-AOOE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ACETAMINOPHEN AND CODEINE, CANDESARTAN, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, BOTULINUM TOXIN TYPE A, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ETANERCEPT, ETANERCEPT, ETANERCEPT, |
||||
| 829 | 25680423 |
CA |
||
Lupus-like syndrome, Arthralgia, Condition aggravated, Fatigue, Hypoaesthesia, Paraesthesia, Skin striae, Peripheral swelling, Pain in extremity, Muscle spasms, Off label use, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, AZATHIOPRINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 830 | 25680710 |
EU |
||
Paraesthesia, Sensory loss, Carpal tunnel decompression, |
||||
VUTRISIRAN, |
||||
| 831 | 25680898 |
US |
54 | 2 |
White blood cell count decreased, Pyrexia, Fatigue, Pain, Paraesthesia, Decreased appetite, Red blood cell count decreased, Platelet count decreased, Full blood count decreased, Migraine, Headache, |
||||
PALBOCICLIB, PALBOCICLIB, INAVOLISIB, CETIRIZINE HYDROCHLORIDE, ZOLEDRONIC ACID, GALCANEZUMAB-GNLM, ELETRIPTAN HYDROBROMIDE, MORPHINE SULFATE, FULVESTRANT, MECLIZINE HCL 12.5 MG, MECLIZINE, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, PROMETHAZINE, PROCHLORPERAZINE MALEATE, |
||||
| 832 | 25681250 |
EU |
35 | 2 |
Abdominal pain, Dysphemia, Paraesthesia, Head discomfort, Ear discomfort, Daydreaming, Muscular weakness, Yawning, Trismus, Dyspnoea, Heart rate increased, Feeling hot, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, |
||||
| 833 | 25681538 |
GB |
65 | 2 |
Paraesthesia, |
||||
| 834 | 25681635 |
CN |
58 | 1 |
Paraesthesia, Headache, Pain, |
||||
PACLITAXEL, CISPLATIN, |
||||
| 835 | 25681763 |
US |
2 | |
Neuropathy peripheral, Vision blurred, Hypoaesthesia, Paraesthesia, |
||||
PALBOCICLIB, |
||||
| 836 | 25681871 |
CA |
44 | 2 |
Swelling, Synovitis, Urticaria, Weight decreased, Weight increased, Wheezing, Wound, X-ray abnormal, Vomiting, Road traffic accident, Night sweats, Obesity, Oedema peripheral, Osteoarthritis, Osteoporosis, Pancreatitis, Paraesthesia, Peripheral venous disease, Pneumonia, Porphyria acute, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rectal haemorrhage, Retinitis, Medication error, Muscle injury, Rheumatoid arthritis, Lupus-like syndrome, Malaise, Musculoskeletal pain, Rheumatoid factor positive, |
||||
SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC SODIUM, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, |
||||
| 837 | 25682217 |
PR |
32 | 1 |
Pain, Pallor, Paraesthesia, Monoplegia, Necrotising fasciitis, Peripheral ischaemia, Rhabdomyolysis, Acute kidney injury, Pulseless electrical activity, Ventricular fibrillation, Acute hepatic failure, Disseminated intravascular coagulation, Unresponsive to stimuli, Hypotension, Substance abuse, |
||||
FENTANYL CITRATE, |
||||
| 838 | 25682296 |
US |
1 | |
Off label use, Nervous system disorder, Insomnia, Stress, Paraesthesia, Neuralgia, Asthenia, Weight decreased, Fatigue, Variant Creutzfeldt-Jakob disease, Encephalopathy, |
||||
CHORIONIC GONADOTROPIN, CHORIONIC GONADOTROPIN, CHORIONIC GONADOTROPIN, TESTOSTERONE, TESTOSTERONE,, |
||||
| 839 | 25682435 |
US |
||
Paraesthesia, Hypoaesthesia, |
||||
SUZETRIGINE, |
||||
| 840 | 25682438 |
US |
42 | 1 |
Paraesthesia, |
||||
SUZETRIGINE, |
||||
| 841 | 25682543 |
CA |
||
Adverse reaction, Ill-defined disorder, Rash, Duodenal ulcer perforation, Insomnia, Epilepsy, Anti-cyclic citrullinated peptide antibody positive, Gastrointestinal disorder, Obesity, Hypersensitivity, Memory impairment, Abdominal distension, Blister, Fatigue, Dizziness, Glossodynia, Fibromyalgia, Asthenia, Hypoaesthesia, Impaired healing, Dyspnoea, Lip dry, Lung disorder, Dry mouth, Muscle injury, Pemphigus, Migraine, Hepatitis, Onychomadesis, Blood cholesterol increased, Alopecia, Nail disorder, Peripheral swelling, Abdominal pain upper, Malaise, Diarrhoea, Inflammation, Hepatic enzyme increased, Abdominal discomfort, Hand deformity, Weight increased, Vomiting, Urticaria, Wheezing, Type 2 diabetes mellitus, Taste disorder, Hypertension, Fall, Hypercholesterolaemia, Dyspepsia, Wound, Decreased appetite, Gastrooesophageal reflux disease, Swelling, Systemic lupus erythematosus, Neck pain, Rheumatic fever, Drug-induced liver injury, Headache, Stomatitis, Injection site reaction, Pericarditis, Peripheral venous disease, Muscle spasms, Infusion related reaction, Depression, Nausea, Night sweats, Coeliac disease, Liver injury, Paraesthesia, Blepharospasm, Confusional state, Irritable bowel syndrome, Drug hypersensitivity, Injury, Back injury, Sleep disorder, Liver function test increased, Synovitis, Pain, Musculoskeletal stiffness, Joint range of motion decreased, Arthropathy, Grip strength decreased, Gait inability, C-reactive protein abnormal, C-reactive protein increased, General physical health deterioration, Muscular weakness, Osteoarthritis, Pain in extremity, Psoriatic arthropathy, Mobility decreased, Rheumatoid arthritis, Facet joint syndrome, Musculoskeletal pain, Bursitis, Finger deformity, Joint swelling, Arthralgia, Condition aggravated, Wound infection, Pneumonia, Breast cancer stage III, Nasopharyngitis, Folliculitis, Helicobacter infection, Onychomycosis, Lower respiratory tract infection, Maternal exposure during pregnancy, Exposure during pregnancy, Live birth, Treatment failure, Therapeutic product effect decreased, Drug ineffective, Drug intolerance, Underdose, Overdose, Incorrect product administration duration, Product use in unapproved indication, Intentional product use issue, Contraindicated product administered, Product label confusion, Product quality issue, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CALCIUM CARBONATE, ANTACID, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, MEPOLIZUMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, ACETAMINOPHEN AND CODEINE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, CANDESARTAN, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, ERENUMAB-AOOE, |
||||
| 842 | 25682557 |
US |
65 | 1 |
Hypoaesthesia, Paraesthesia, Fatigue, Oedema, Limb discomfort, |
||||
LENALIDOMIDE, LENALIDOMIDE, |
||||
| 843 | 25682589 |
EU |
38 | 1 |
Suicidal ideation, Abdominal pain, Irritability, Asthenia, Muscular weakness, Aggression, Paraesthesia, Product substitution issue, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
| 844 | 25682631 |
GB |
2 | |
Paraesthesia, |
||||
TIRZEPATIDE, |
||||
| 845 | 25682738 |
CA |
36 | 1 |
Hypoaesthesia, Panic reaction, Paraesthesia, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, |
||||
| 846 | 25682893 |
AR |
25 | 2 |
Syringomyelia, Paraesthesia, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 847 | 25683062 |
US |
41 | 2 |
Paraesthesia, Injection site pain, Injection site hypoaesthesia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 848 | 25683722 |
US |
18 | 2 |
Paraesthesia, Dizziness, |
||||
DUPILUMAB, |
||||
| 849 | 25683731 |
US |
61 | 1 |
Paraesthesia, |
||||
DUPILUMAB, |
||||
| 850 | 25673040 |
US |
82 | 2 |
Hypoaesthesia, Paraesthesia, Drug ineffective for unapproved indication, Off label use, |
||||
DENOSUMAB, PREDNISONE, PREDNISONE, |
||||
| 851 | 25673174 |
US |
2 | |
Multiple sclerosis, Multiple sclerosis relapse, Blindness, Dysphagia, Paraesthesia, Unevaluable event, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
| 852 | 25673222 |
US |
46 | 2 |
Neck surgery, Hypoaesthesia, Rheumatoid arthritis, Paraesthesia, Nerve compression, Intervertebral disc protrusion, |
||||
UPADACITINIB, GABAPENTIN, SPIRONOLACTONE, FAMOTIDINE, |
||||
| 853 | 25673244 |
CA |
37 | 2 |
Ear pruritus, Erythema, Herpes zoster, Nasal congestion, Nasopharyngitis, Off label use, Oropharyngeal pain, Paraesthesia, Pharyngeal swelling, Productive cough, Rash, Rash erythematous, Throat irritation, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 854 | 25673628 |
US |
50 | 2 |
Hypersensitivity, Paraesthesia, Swelling, Eye irritation, Feeling abnormal, Lip swelling, Eye swelling, Urticaria, Chest pain, Headache, Suspected product quality issue, |
||||
OXYCODONE, OXYCODONE, LEVOTHYROXINE, ALPRAZOLAM, |
||||
| 855 | 25673661 |
US |
2 | |
Blood glucose decreased, Headache, Stress, Back pain, Paraesthesia, |
||||
EMPAGLIFLOZIN, SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 856 | 25673693 |
EU |
41 | 2 |
Muscular weakness, Limb discomfort, Paraesthesia, Grip strength decreased, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, LOSARTAN, |
||||
| 857 | 25673957 |
GB |
65 | 2 |
Paraesthesia, |
||||
| 858 | 25674286 |
CA |
75 | 1 |
Asthma, Cardiac failure congestive, Chronic obstructive pulmonary disease, Full blood count abnormal, Loss of personal independence in daily activities, Lung disorder, Neuropathy peripheral, Paraesthesia, Pneumonia, Sensory disturbance, Sleep disorder due to a general medical condition, Sputum discoloured, Tachycardia, Muscle spasms, Dyspnoea, Wheezing, Therapeutic product effect incomplete, Therapeutic response shortened, |
||||
DUPILUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, PREDNISONE, PREGABALIN, BENRALIZUMAB, BUPRENORPHINE, ROFLUMILAST, DEXLANSOPRAZOLE, GABAPENTIN ENACARBIL, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, MOMETASONE, MEPOLIZUMAB, MEPOLIZUMAB, MOXIFLOXACIN HYDROCHLORIDE, MEPOLIZUMAB, OMALIZUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, GLYCOPYRROLATE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, THEOPHYLLINE, |
||||
| 859 | 25674478 |
CA |
76 | 2 |
Pain, Paraesthesia, |
||||
NIVOLUMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AMLODIPINE, CHLORTHALIDONE, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 860 | 25674561 |
US |
||
Hypoaesthesia, Paraesthesia, Inappropriate schedule of product administration, Paraesthesia, |
||||
CEPHALEXIN, CEPHALEXIN, |
||||
| 861 | 25674564 |
US |
65 | 2 |
Hypoaesthesia, Paraesthesia, |
||||
OMALIZUMAB, |
||||
| 862 | 25674641 |
EU |
||
Paraesthesia, Head discomfort, Decreased appetite, Constipation, Abdominal distension, Weight decreased, Feeling abnormal, Blood pressure decreased, Dizziness, Fatigue, |
||||
RIVAROXABAN, |
||||
| 863 | 25674970 |
EU |
||
Neuropathy peripheral, Urinary tract infection, Chills, Hair growth abnormal, Balance disorder, Feeling abnormal, Paraesthesia, Fatigue, Diarrhoea, Nausea, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, ABEMACICLIB, |
||||
| 864 | 25675066 |
EU |
63 | 1 |
Swelling face, Polyneuropathy, Paraesthesia, |
||||
OXALIPLATIN, CAPECITABINE, |
||||
| 865 | 25675262 |
US |
66 | 1 |
Dysgeusia, Paraesthesia, Blood pressure increased, Incorrect dose administered, |
||||
RELUGOLIX, CALCIUM, MONTELUKAST, DAROLUTAMIDE, TELMISARTAN AND HYDROCHLOROTHIAZIDE, ERGOCALCIFEROL, |
||||
| 866 | 25675686 |
GB |
1 | |
Musculoskeletal stiffness, Paraesthesia, |
||||
| 867 | 25676693 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Decreased appetite, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Incorrect product administration duration, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Off label use, Onychomadesis, Onychomycosis, Osteoarthritis, Overdose, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Underdose, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event, Hospitalisation, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MEPOLIZUMAB, |
||||
| 868 | 25676892 |
US |
2 | |
Paraesthesia, Dry eye, Drug ineffective, Product quality issue, |
||||
GLYCOPYRRONIUM, OCRELIZUMAB, SERTRALINE HYDROCHLORIDE, PROGESTERONE, |
||||
| 869 | 25676966 |
CA |
43 | 2 |
Abdominal discomfort, Taste disorder, Migraine, Rheumatoid arthritis, C-reactive protein increased, Pemphigus, Wound infection, Wheezing, General physical health deterioration, Muscle spasms, Stomatitis, Dizziness, Peripheral venous disease, Hepatic enzyme increased, Arthropathy, Live birth, Abdominal pain upper, Urticaria, Rash, Synovitis, Inflammation, Alopecia, Headache, Paraesthesia, Pericarditis, Arthralgia, Nail disorder, Product quality issue, Blepharospasm, Fatigue, Impaired healing, Hand deformity, Lower respiratory tract infection, Liver injury, Vomiting, Exposure during pregnancy, Mobility decreased, Facet joint syndrome, Infusion related reaction, Type 2 diabetes mellitus, Helicobacter infection, Systemic lupus erythematosus, Peripheral swelling, Musculoskeletal pain, Contraindicated product administered, Irritable bowel syndrome, Wound, Hypoaesthesia, Fibromyalgia, Lung disorder, Confusional state, Condition aggravated, Dry mouth, Pain, Diarrhoea, Maternal exposure during pregnancy, Decreased appetite, Nasopharyngitis, Folliculitis, Bursitis, Blood cholesterol increased, Epilepsy, Glossodynia, Hypertension, Memory impairment, Psoriatic arthropathy, Hypocholesterolaemia, Lip dry, Obesity, Gastrooesophageal reflux disease, Swelling, Joint swelling, Night sweats, Breast cancer stage III, Depression, Anti-cyclic citrullinated peptide antibody positive, Asthenia, Weight increased, Joint range of motion decreased, Osteoarthritis, Duodenal ulcer perforation, Blister, Muscle injury, |
||||
CANDESARTAN, LORAZEPAM, LISINOPRIL, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LORAZEPAM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, BUPRENORPHINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, HYDROXYCHLOROQUINE SULFATE, TOFACITINIB, LEFLUNOMIDE, PREDNISONE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, OXYCODONE, FISH OIL, QUETIAPINE FUMARATE, QUETIAPINE, DESOXIMETASONE, LEFLUNOMIDE, LEFLUNOMIDE, METHYLPREDNISOLONE, CYANOCOBALAMIN, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, RISEDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, RAMIPRIL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ATOMOXETINE, LANSOPRAZOLE, PANTOPRAZOLE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, PREDNISONE, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, TOFACITINIB, TOFACITINIB, NAPROXEN, NAPROXEN SODIUM, SARILUMAB, RANITIDINE, CORTISONE ACETATE, CORTISONE ACETATE, ERENUMAB-AOOE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, ABATACEPT, ABATACEPT, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CALCIUM, APREMILAST, BOTULINUM TOXIN TYPE A, TRAMADOL HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, USTEKINUMAB, RITUXIMAB, RITUXIMAB, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, MEPOLIZUMAB, ETANERCEPT, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, SECUKINUMAB, SECUKINUMAB, LAMOTRIGINE, LAMOTRIGINE, |
||||
| 870 | 25677437 |
US |
35 | 2 |
Abortion spontaneous, Temperature regulation disorder, COVID-19, Headache, Arthralgia, Hypoaesthesia, Paraesthesia, Drug specific antibody present, Maternal exposure during pregnancy, |
||||
ADALIMUMAB, |
||||
| 871 | 25677549 |
US |
56 | 1 |
Blood pressure systolic decreased, Chest discomfort, Dyspnoea, Paraesthesia, Epigastric discomfort, |
||||
FERRIC CARBOXYMALTOSE, FERRIC CARBOXYMALTOSE, FERROUS SULFATE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 872 | 25677555 |
EU |
||
Drug dependence, Paraesthesia, Hypoaesthesia, Memory impairment, Palpitations, Nightmare, Tremor, Vertigo, Headache, Coordination abnormal, Fall, Nausea, Dry mouth, Saliva altered, Ageusia, Vision blurred, Hypotension, Heart rate irregular, Somnolence, Weight decreased, Drug withdrawal syndrome, Off label use, |
||||
DIAZEPAM, DIAZEPAM, DIAZEPAM, PAROXETINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, |
||||
| 873 | 25677704 |
US |
2 | |
Drug hypersensitivity, Throat tightness, Hypoaesthesia, Tachycardia, Asthenia, Chest discomfort, Blood pressure increased, Paraesthesia, |
||||
VEDOLIZUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 874 | 25677757 |
EU |
49 | 1 |
Electric shock sensation, Paraesthesia, Discomfort, Withdrawal syndrome, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 875 | 25678157 |
US |
||
Paraesthesia, Electric shock sensation, Skin weeping, Skin induration, Scab, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 876 | 25681395 |
50 | 1 | |
Tendon pain, Pain in extremity, Headache, Muscle twitching, Impulse-control disorder, Therapy cessation, Paraesthesia, Body temperature increased, Pain in extremity, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, MAGNESIUM, ERGOCALCIFEROL, |
||||
| 877 | 25667746 |
CA |
46 | 1 |
Gout, Sinusitis, Staphylococcal infection, Joint swelling, Arthralgia, Malaise, Headache, Paraesthesia, Toothache, Hypertension, |
||||
INFLIXIMAB, INFLIXIMAB, SERTRALINE HYDROCHLORIDE, PREDNISONE, |
||||
| 878 | 25668709 |
CA |
75 | 1 |
Cardiac failure congestive, Asthma, Chronic obstructive pulmonary disease, Dyspnoea, Full blood count abnormal, Loss of personal independence in daily activities, Lung disorder, Muscle spasms, Neuropathy peripheral, Paraesthesia, Pneumonia, Sensory disturbance, Sleep disorder due to a general medical condition, Sputum discoloured, Wheezing, Tachycardia, Therapeutic response shortened, Therapeutic product effect incomplete, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, BUDESONIDE, BENRALIZUMAB, CALCIUM CARBONATE, BUPRENORPHINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ROFLUMILAST, DEXLANSOPRAZOLE, DUPILUMAB, GABAPENTIN ENACARBIL, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MOMETASONE, MOXIFLOXACIN HYDROCHLORIDE, MEPOLIZUMAB, MEPOLIZUMAB, OMALIZUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, PREGABALIN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, GLYCOPYRROLATE, MONTELUKAST SODIUM, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, THEOPHYLLINE, |
||||
| 879 | 25668813 |
MA |
51 | 2 |
Syncope, Disease recurrence, Limb discomfort, Paraesthesia, Fatigue, Stress, |
||||
INTERFERON BETA-1A, |
||||
| 880 | 25669122 |
GB |
30 | 2 |
Neuropathy peripheral, Anxiety, Depression, Tendon injury, Chest pain, Swelling, Fatigue, Localised infection, Muscular weakness, Obsessive thoughts, Dizziness, Brain fog, Pain, Neuralgia, Paraesthesia, Nocturia, Cystitis interstitial, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 881 | 25669976 |
US |
2 | |
Body temperature increased, Urticaria, Off label use, Paraesthesia, Mouth swelling, |
||||
OMALIZUMAB, |
||||
| 882 | 25670301 |
EU |
71 | 1 |
Azotaemia, Asthenia, Paraesthesia, Constipation, |
||||
OXALIPLATIN, OXALIPLATIN, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, CAPECITABINE, CAPECITABINE, CAPECITABINE, |
||||
| 883 | 25670322 |
US |
61 | 2 |
Cough, Dysphonia, Rash, Paraesthesia, Gastrooesophageal reflux disease, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, PANTOPRAZOLE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, |
||||
| 884 | 25670386 |
55 | 1 | |
Rash, Erythema, Skin irritation, Pruritus, Paraesthesia, |
||||
CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, METHYLPREDNISOLONE SODIUM SUCCINATE, DULOXETINE HYDROCHLORIDE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 885 | 25670555 |
64 | 2 | |
Paraesthesia, Neuralgia, Pain in extremity, Hypoaesthesia, Sleep disorder, |
||||
NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), |
||||
| 886 | 25670589 |
US |
1 | |
Neuropathy peripheral, Pyrexia, Malaise, Ageusia, Dyspnoea, Fatigue, Oral pain, Paraesthesia, |
||||
TALQUETAMAB, |
||||
| 887 | 25670590 |
US |
53 | 1 |
Hypersensitivity, Burning sensation, Rash, Paraesthesia, Off label use, |
||||
DUPILUMAB, |
||||
| 888 | 25670616 |
IN |
||
Generalised tonic-clonic seizure, Intentional overdose, Loss of consciousness, Drug abuse, Drug dependence, Asthenia, Hypoaesthesia, Gastrointestinal disorder, Paraesthesia, Depressed mood, Sleep disorder, Confusional state, Dyspnoea, Headache, Irritability, Withdrawal syndrome, |
||||
PREGABALIN, PREGABALIN, PREGABALIN, PREGABALIN, |
||||
| 889 | 25670875 |
CA |
||
Coeliac disease, Confusional state, Blood cholesterol increased, Blepharospasm, Breast cancer stage III, Blister, Dizziness, Diarrhoea, Dry mouth, Depression, Asthenia, Stomatitis, Adverse reaction, Sleep disorder, Swelling, Alopecia, Arthralgia, Abdominal pain upper, Back injury, Abdominal distension, Abdominal discomfort, Memory impairment, Malaise, Migraine, Lower respiratory tract infection, Liver function test increased, Lung disorder, Nail disorder, Nasopharyngitis, Musculoskeletal stiffness, Nausea, Muscle injury, Muscle spasms, Muscular weakness, Epilepsy, Fall, Fatigue, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Gastrointestinal disorder, Gastrooesophageal reflux disease, Fibromyalgia, Folliculitis, Impaired healing, Liver injury, General physical health deterioration, Helicobacter infection, Drug-induced liver injury, Wound infection, Wound, Wheezing, Drug hypersensitivity, Hepatitis, Hepatic enzyme increased, Headache, Hypersensitivity, Hypercholesterolaemia, Onychomadesis, Obesity, Synovitis, Systemic lupus erythematosus, Neck pain, Night sweats, Vomiting, Urticaria, Weight increased, Taste disorder, Loss of personal independence in daily activities, Type 2 diabetes mellitus, Pemphigus, Peripheral swelling, Pain in extremity, Pericarditis, Pain, Onychomycosis, Paraesthesia, Rash, Pneumonia, Peripheral venous disease, Infusion related reaction, Injection site reaction, Inflammation, Injury, Insomnia, Hypertension, Ill-defined disorder, Condition aggravated, Lip dry, Irritable bowel syndrome, Therapeutic product effect decreased, Treatment failure, Live birth, Drug ineffective, Drug intolerance, Osteoarthritis, Psoriatic arthropathy, Joint swelling, Rheumatoid arthritis, Mobility decreased, Glossodynia, Arthropathy, Facet joint syndrome, Grip strength decreased, Bursitis, Finger deformity, Joint range of motion decreased, Gait inability, Hand deformity, C-reactive protein abnormal, Anti-cyclic citrullinated peptide antibody positive, Rheumatic fever, Maternal exposure during pregnancy, Product label confusion, Exposure during pregnancy, Contraindicated product administered, Intentional product use issue, Product quality issue, Product use in unapproved indication, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, AZATHIOPRINE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ATOMOXETINE, ATOMOXETINE, AZATHIOPRINE, ERENUMAB-AOOE, ERENUMAB-AOOE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BUPRENORPHINE, BOTULINUM TOXIN TYPE A, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHYLPREDNISOLONE, MEPOLIZUMAB, NICOTINAMIDE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, ASCORBIC ACID, ASCORBIC ACID, RETINOL, RETINOL, TOFACITINIB, TOFACITINIB, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, SECUKINUMAB, SECUKINUMAB, |
||||
| 890 | 25671177 |
EU |
69 | 1 |
Restlessness, Urticaria, Throat tightness, Blood pressure abnormal, Burning sensation, Asthenia, Hypoaesthesia, Paraesthesia, Cold sweat, |
||||
CETUXIMAB, |
||||
| 891 | 25671314 |
EU |
59 | 1 |
Skin toxicity, Mucosal inflammation, Paraesthesia, Diarrhoea, Nausea, |
||||
PEMBROLIZUMAB, CARBOPLATIN, PACLITAXEL, |
||||
| 892 | 25671444 |
US |
54 | 1 |
Multiple sclerosis, Muscular weakness, Headache, Fatigue, Sensory disturbance, Paraesthesia, Drug intolerance, |
||||
OFATUMUMAB, OFATUMUMAB, FINGOLIMOD HCL, |
||||
| 893 | 25671526 |
CA |
44 | 2 |
Lung disorder, Prescribed overdose, Psoriatic arthropathy, Rheumatoid factor positive, Road traffic accident, Sciatica, Peripheral venous disease, Malaise, Mobility decreased, Muscle spasms, Musculoskeletal pain, Obesity, Oedema, Osteoarthritis, Paraesthesia, Liver disorder, Liver injury, Lower limb fracture, Therapy non-responder, Treatment failure, Hypoaesthesia, Infection, Abdominal pain upper, Adjustment disorder with depressed mood, Amnesia, Arthritis, Asthenia, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, Colitis ulcerative, Condition aggravated, Delirium, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Dry mouth, Feeling hot, Frequent bowel movements, General physical health deterioration, Headache, Hypertension, Sleep disorder, Urticaria, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, QUETIAPINE FUMARATE, QUETIAPINE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, ERGOCALCIFEROL, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB-DYYB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN AND CODEINE, PREDNISONE, PREDNISONE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, DEXTROMETHORPHAN HYDROBROMIDE, IODINE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ISOSORBIDE DINITRATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LANSOPRAZOLE, LANSOPRAZOLE, ERGOCALCIFEROL, |
||||
| 894 | 25671537 |
EU |
68 | 2 |
Gastrointestinal disorder, Paraesthesia, Dyspnoea, Asthenia, Thrombocytopenia, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 895 | 25671562 |
GB |
29 | 1 |
Dysarthria, Tremor, Paraesthesia, Vomiting, Hyperhidrosis, Musculoskeletal stiffness, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, BISOPROLOL FUMARATE, |
||||
| 896 | 25671636 |
GB |
35 | 2 |
Paraesthesia, Paraesthesia oral, Chest discomfort, Insomnia, |
||||
TIRZEPATIDE, |
||||
| 897 | 25671674 |
US |
||
Cardiac hypertrophy, Cognitive disorder, Ventricular tachycardia, Trigger finger, Paraesthesia, Sensorimotor disorder, |
||||
VUTRISIRAN, |
||||
| 898 | 25671894 |
CA |
78 | 1 |
Arthralgia, Asthma, Hypoaesthesia, Muscle spasms, Neck pain, Neuropathy peripheral, Pain in extremity, Paraesthesia, Sensory disturbance, Headache, Dizziness, Inappropriate schedule of product administration, |
||||
ALBUTEROL SULFATE, ALBUTEROL, MEPOLIZUMAB, GABAPENTIN, |
||||
| 899 | 25671943 |
US |
2 | |
Arthralgia, Paraesthesia, Carpal tunnel syndrome, Abdominal pain upper, Discomfort, Joint swelling, |
||||
| 900 | 25671964 |
US |
86 | 2 |
Macular degeneration, Paraesthesia, Visual impairment, |
||||
ADALIMUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30
